Choose Your News
Loading...
Thumbnail
Gilead Sciences establishes proof of concept data showing that a combination of cilofexor and firsocostat achieved a 30% reduction in hepatic liver fat in 12... [Read More]
Gilead Sciences (GILD) is up 1% premarket on light volume in reaction to its three-year collaboration with privately held insitro to discover and developme... [Read More]
Preview